Tumour Models Summit Nordics
April 9 - 10, 2025 - SEHanson Wade
info@hansonwade.com
Phone:02031418700
The inherent heterogeneity of cancer - both inter-patient and intra-tumoral – remains a significant challenge in cancer modeling. With only 5% of cancer drugs successfully advancing to clinical trials, there is a critical need for more accurate and predictive models to guide therapeutic development. For the first time, the Tumour Models Summit Nordics unites pharma, biotech, and research leaders across the thriving Nordic biotech ecosystem to tackle this challenge head-on. As the region's only industry-led event of its kind, this summit provides a rare opportunity to connect with top experts in preclinical and translational research. Gain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling, discover strategies to de-risk your studies, and learn how to refine your drug development pipeline. Join us to engage with decision-makers, explore ground breaking solutions, and accelerate the path from lab to patient in today's rapidly evolving landscape. Time: 08:00 to 17:00